Clinical Trial Update: A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid [Phase 1]

View source ↗

Summary

This Phase 1 randomized, crossover trial evaluated two fixed-dose inhaled LABA/corticosteroid combinations for asthma and is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fixed-dose inhaled LABA/corticosteroid combination A
• Fixed-dose inhaled LABA/corticosteroid combination B

Snippet

Sponsor: Almirall, S.A. | Conditions: Asthma | Phase 1 | Status: COMPLETED